ECC: Everolimus Effective in Advanced Papillary Renal Cell Carcinoma Cancer Network “Our clinical findings are encouraging and suggest that everolimus may represent a new treatment option,” Escudier said. In the open-label, phase II RAPTOR trial, Escudier and colleagues from six countries enrolled 92 treatment-naive patients with ECOG ... |
